Stay updated on AK104 in NSCLC Phase II Clinical Trial
Sign up to get notified when there's something new on the AK104 in NSCLC Phase II Clinical Trial page.

Latest updates to the AK104 in NSCLC Phase II Clinical Trial page
- Check5 days agoChange DetectedThe version history shows updates to recruitment status (and study status) for the AK104 trial in advanced non-small cell lung cancer on 2022-03-24 and 2025-03-10, with the latest entry indicating the current recruitment status.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check34 days agoChange DetectedVersion bump to v3.2.0 accompanied by a government-operating-status notice; replaces v3.1.0.SummaryDifference13%

- Check41 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.3%

- Check55 days agoChange DetectedRevision updated to v3.0.2 and the Back to Top element was removed. No core content, pricing, stock, or time-slot information is affected.SummaryDifference0.8%

- Check62 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.8%

- Check69 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location details, while removing specific state, country, and city information.SummaryDifference8%

Stay in the know with updates to AK104 in NSCLC Phase II Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AK104 in NSCLC Phase II Clinical Trial page.